Erythropoietin Nanopariticles: Therapy for Cerebral Ischemic Injury and Metabolize in Kidney
Ischemic metabolism in the enterogram is a crucial issue of clinical concern for deep understanding of drug delivery. In this study we use nanochemistry in micelle to produce the nanocarrier of erythropoietin (EPO) and traced the metabolizable process of the EPO carrier in vivo. Nascence Sprague-Daw...
Main Authors: | Ting Wang, Yan Hu, Long Zhang, Li Jiang, Nongyue He |
---|---|
Format: | Article |
Language: | English |
Published: |
Tsinghua University Press
2010-03-01
|
Series: | Nano Biomedicine and Engineering |
Subjects: | |
Online Access: | https://www.sciopen.com/article/10.5101/nbe.v2i1.p31-39 |
Similar Items
-
Erythropoietin Reduces Death and Neurodevelopmental Impairment in Neonatal Hypoxic-Ischemic Encephalopathy
by: Seung Jun Bang, et al.
Published: (2022-11-01) -
Diagnostic Value of Erythropoietin Levels in Umbilical Cord Blood in Hypoxic-Ischemic Brain Injury: Clinical Observational Cross-Sectional Study
by: S. B. Berezhanskaya, et al.
Published: (2022-12-01) -
Upregulation of erythropoietin and erythropoietin receptor in castration-resistant progression of prostate cancer
by: Chen Ye, et al.
Published: (2020-01-01) -
A Review of Pleiotropic Potential of Erythropoietin as an Adjunctive Therapy for COVID-19
by: Fatemeh EmamiPari, et al.
Published: (2022-02-01) -
Systemic and cerebral vascular endothelial growth factor levels increase in murine cerebral malaria along with increased calpain and caspase activity and can be reduced by erythropoietin treatment
by: Casper eHempel, et al.
Published: (2014-06-01)